The Role of Amnion Membrane Allografts in Nipple Preservation
NCT: NCT06073808 · NOT_YET_RECRUITING
Brief Summary
The overall objective of this proposal is to conduct a randomized-controlled study to determine whether treatment with dehydrated human amnion/chorion membrane (dHACMs) allografts can improve NAC viability in patients undergoing nipple sparing mastectomy (NSM). dHACM allografts are commercially available tissue membranes with biocompatible extracellular matrix and growth factors that have been shown to improve wound healing in patients with chronic and lower extremity wounds. To date, no study has evaluated the impact of dHACMs on NAC preservation following NSM. Investigators hypothesize that subareolar surgical implantation of dHACM allografts at time of NSM will reduce NAC necrosis and improve viability.
Frequently Asked Questions
What is The Role of Amnion Membrane Allografts in Nipple Preservation?
The Role of Amnion Membrane Allografts in Nipple Preservation is a clinical trial registered under NCT06073808. Current status: NOT_YET_RECRUITING.
What is the status of NCT06073808?
The current status of NCT06073808 (The Role of Amnion Membrane Allografts in Nipple Preservation) is: NOT_YET_RECRUITING.
When did The Role of Amnion Membrane Allografts in Nipple Preservation start?
The Role of Amnion Membrane Allografts in Nipple Preservation started on 2026-06-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.